Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

BACKGROUND: Giant cell tumor of bone (GCTB) is an intermediate tumor known to be locally aggressive, but rarely metastasizing. To plan a prospective study of GCTB, we performed a questionnaire survey for institutions participating in the Bone and Soft Tissue Tumor Study Group (BSTTSG) in the Japan C...

Descripción completa

Detalles Bibliográficos
Autores principales: Urakawa, Hiroshi, Yonemoto, Tsukasa, Matsumoto, Seiichi, Takagi, Tatsuya, Asanuma, Kunihiro, Watanuki, Munenori, Takemoto, Akira, Naka, Norifumi, Matsumoto, Yoshihiro, Kawai, Akira, Kunisada, Toshiyuki, Kubo, Tadahiko, Emori, Makoto, Hiraga, Hiroaki, Hatano, Hiroshi, Tsukushi, Satoshi, Nishida, Yoshihiro, Akisue, Toshihiro, Morii, Takeshi, Takahashi, Mitsuru, Nagano, Akihito, Yoshikawa, Hideki, Sato, Kenji, Kawano, Masanori, Hiraoka, Koji, Tanaka, Kazuhiro, Iwamoto, Yukihide, Ozaki, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083623/
https://www.ncbi.nlm.nih.gov/pubmed/30089488
http://dx.doi.org/10.1186/s12957-018-1459-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083623/
https://www.ncbi.nlm.nih.gov/pubmed/30089488
http://dx.doi.org/10.1186/s12957-018-1459-6

Ejemplares similares